Application of drosophila melanogaster Hsp22 protein in preparation of anti-tumor drug
An anti-tumor and protein technology, applied in the field of medicine, can solve problems such as the urgent demand for anti-cancer drugs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] Example 1 Treatment of Drosophila Hsp22 Protein to Ras Tumor Drosophila Model
[0023] (1) Construction of Drosophila tumor model
[0024] ①Construction of RasV12; scrib- / - Drosophila tumor model (overexpression of oncoprotein Ras and recessive homozygous mutation of tumor suppressor gene scrib- / -)
[0025] The promoter scrib-GAL4, which is selectively expressed in the eye disc and abdominal nerve cord of Drosophila larvae, was crossed with RasV12 fruit flies labeled with GFP fluorescence (the fruit flies were donated by Professor Xue Lei from the School of Life Sciences, Tongji University, Shanghai ), the obtained F1 generation is RasV12; scrib- / - tumor Drosophila (overexpression of the oncoprotein Ras and scrib-recessive homozygous mutation).
[0026] ② Construction of hsp22 overexpressed RasV12; scrib- / - tumor Drosophila
[0027] Cross hsp22 overexpression flies (genotype: + / cyo; hsp22 OE / TM2) with RasV12 flies (genotype: RasV12 / sco; TM3 / +), and screen RasV12 / cyo; ...
Embodiment 2
[0034] Example 2 Drosophila Hsp22 protein treatment of mouse liver cancer
[0035] (1) Construction of monoclonal bacteria
[0036] The whole gene synthesis of the Drosophila Hsp22 protein gene sequence (the amino acid sequence is shown in SEQ ID NO: 1, and the nucleotide sequence is shown in SEQ ID NO: 2), after being digested with BamHI and XhoI, inserted into the pET28a vector to obtain After the recombinant plasmid is sequenced correctly, the recombinant plasmid is transformed into the host bacterium Escherichia coli to obtain monoclonal bacteria.
[0037] (2) Drosophila Hsp22 protein expression
[0038]Configure the culture medium, sterilize, and apply the monoclonal bacteria obtained in step (1) to a kanamycin (KA) plate at night, overnight. The next day, select monoclonal bacteria into 10ml of KA (50ug / ml) liquid medium, and overnight at 250rpm and 37°C. On the third day, transfer 1% overnight bacteria to 1000ml of liquid medium, expand and shake the bacteria at 250r...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com